H.-D. Yin, M. Hong, H.-L. Xu, Z.-J. Gao, G. Li, D.-Q. Wang
FULL PAPER
ArCH2Sn), 6.63–7.39 (m, 16 H, Ph-H), 7.78 (d, J = 4.80 Hz, 4 H,
3,5-pyridine-H), 8.89 (d, J = 6.40 Hz, 4 H, 2,6-pyridine-H) ppm.
119Sn NMR (CDCl3): δ = –449.8 ppm.
was evaporated under vacuum to form a white solid and recrys-
tallized from methanol to give colorless crystals. Yield: 85%
(111.8 mg). M.p. 131 °C. C50H48Cl4N4O10Sn2 (1244.1): calcd. C
48.27, H 3.89, N, 4.49; found C 48.36, H 3.71, N 4.55. IR (KBr):
[(pCNBz)2Sn{4-NC5H4CON2C(CH3)CO2}]2 (6): Complex 6 was
prepared in the same way as 3 by adding tri-p-cyanobenzyltin chlo-
ride (2.0 mmol) to pyruvic acid isonicotinyl hydrazone (2.0 mmol).
The solid was then obtained from methanol. Yield: 91%
(115.8 mg). M.p. 210 °C. C50H38N10O6Sn2 (1112.3): calcd. C 53.98,
ν = 3417 cm–1 (m, OH), 3021 (m, Ar–H), 2916 (m, C–H), 1618 (m,
˜
C=N), 1603 (s, C=N–N=C), 1586, 1321 (s, CO2), 1209 (m, C–O),
1
677 (m, Sn–O), 525 (w, Sn–C), 465 (w, Sn–N). H NMR (CDCl3,
400 MHz): δ = 1.66 (s, 12 H, CH3), 3.39 (s, 8 H, ArCH2Sn), 6.84–
7.59 (m, 24 H, Ar-H and Ph-H), 8.09 (s, 2 H, R-OH), 11.16 (s, 2
H, Ar-OH) ppm. 119Sn NMR (CDCl3): δ = –445.8 ppm.
H 3.42, N 12.60; found C 53.62, H 3.41, N 12.77. IR (KBr): ν =
˜
3007 cm–1 (m, Ar–H), 2922, 2852 (s, C–H), 1630 (m, C=N), 1619,
1385 (m, CO2), 1602 (m, C=N–N=C), 1200 (m, C–O), 692 (m, Sn–
[(pClBz)2Sn{2-HOC6H4CON2C(CH3)CO2}]2 (11): Complex 11 was
prepared in the same way as 10 by adding tri-p-chlorobenzyltin
chloride (2.0 mmol) to pyruvic acid salicylhydrazone (2.0 mmol).
The solid was then obtained from methanol. Yield: 87%
(115.3 mg). M.p. 144 °C. C48H40Cl4N4O8Sn2 (1179.6): calcd. C
1
O), 540 (w, Sn–C), 478 (w, Sn–N). H NMR (CDCl3, 400 MHz): δ
= 2.42 (s, 6 H, CH3), 3.08 (s, ArCH2Sn), 7.21–7.35 (m, 16 H, Ph-
H), 7.22 (d, J = 8.00 Hz, 4 H, 3,5-pyridine-H), 7.57 (d, J = 8.40 Hz,
4 H, 2,6-pyridine-H) ppm. 119Sn NMR (CDCl3): δ = –453.9 ppm.
48.84, H 3.39, N 4.75; found C 48.91, H 3.47, N 4.62. IR (KBr): ν
˜
[(nBu)2Sn{2-HOC6H4CON2C(CH3)CO2}{(nBu)3SnOH}]2 (7): Py-
ruvic acid salicylhydrazone (1.0 mmol) was added to a benzene sus-
pension (30 mL) of bis(tri-n-butyltin) oxide (1.0 mmol), then the
mixture was stirred and heated at reflux for 6 h. The clear solution
obtained after fliteration was evaporated in vacuo to give a solid,
which was then recrystallized from dichloromethane/hexane to give
colorless crystals. Yield: 83% (71.5 mg). M.p. 101 °C.
C30H54N2O5Sn2 (759.12): calcd. C 47.40, H 7.16, N 3.68; found C
= 3379 cm–1 (s, OH), 3023 (m, Ar–H), 2916 (m, C–H), 1633 (m,
C=N), 1602 (s, C=N–N=C), 1594, 1367 (s, CO2), 1202 (m, C–O),
1
685 (m, Sn–O), 525 (w, Sn–C), 474 (w, Sn–N). H NMR (CDCl3,
400 MHz): δ = 1.66 (s, 6 H, CH3), 3.26 (s, 8 H, ArCH2Sn), 6.26–
7.63 (m, 24 H, Ar-H and Ph-H), 11.18 (s, 2 H, Ar-OH) ppm. 119Sn
NMR (CDCl3): δ = –443.5 ppm.
[(pCNBz)2Sn{2-HOC6H4CON2C(CH3)CO2}]2 (12): Complex 12
was prepared in the same way as 10 by adding tri-p-cyanobenzyltin
chloride (2.0 mmol) to pyruvic acid salicylhydrazone (2.0 mmol).
The solid was then obtained from methanol. Yield: 72% (92.1 mg).
M.p. 215 °C. C52H40N8O8Sn2 (1142.3): calcd. C 54.67, H 3.53, N
47.32, H 7.15, N 3.77. IR (KBr): ν = 3423 cm–1 (m, OH), 2955 (s,
˜
Ar–H), 2922, 2853 (s, C–H), 1627 (m, C=N), 1608, 1334 (s, CO2),
1583 (m, C=N–N=C), 1205 (s, C–O), 672 (m, Sn–O), 560 (w, Sn–
1
C), 502 (w, Sn–N). H NMR (CDCl3, 400 MHz): δ = 0.83 (t, J =
9.81; found C 54.81, H 3.44, N 9.72. IR (KBr): ν = 3411 cm–1 (m,
6.40 Hz, 15 H, CH3), 1.19–1.61 (m, 30 H, SnCH2CH2CH2), 2.38
(s, 3 H, CH3), 6.88–7.35 (m, 4 H, Ph-H), 11.22 (s, 1 H, Ar-OH)
ppm. 119Sn NMR (CDCl3): δ = 102.3, –453.9 ppm.
˜
OH), 3102 (m, Ar–H), 2922 (m, C–H), 1612 (m, C=N), 1600 (m,
C=N–N=C), 1588, 1352 (s, CO2), 1206 (m, C–O), 677 (w, Sn–O),
1
523 (m, Sn–C), 459 (w, Sn–N). H NMR (CDCl3, 400 MHz): δ =
[Bz2Sn{2-HOC6H4CON2C(CH3)CO2}{Bz3SnOH}]2 (8): Complex 8
was prepared in the same way as 7 by adding bis(tribenzyltin) oxide
(1.0 mmol) to pyruvic acid salicylhydrazone (1.0 mmol). The solid
was then obtained from dichloromethane/hexane. Yield: 91%
(82.2 mg). M.p. 215 °C. C45H43N2O5Sn2 (929.25): calcd. C 58.10,
1.52 (s, 6 H, CH3), 3.35 (s, 8 H, ArCH2Sn), 6.35–7.61 (m, 24 H,
Ar-H and Ph-H), 10.87 (s, 2 H, Ar-OH) ppm. 119Sn NMR (CDCl3):
δ = –452.8 ppm.
X-ray Crystallographic Study: All measurements were made on a
Bruker Smart 1000 CCD diffractometer at 298(2) K with graphite-
monochromated Mo-Kα (λ = 0.71073 Å). Semi-empirical absorp-
tion corrections were applied using the SADABS program. The
structures were solved by direct methods and difference Fourier
maps using SHELXL-97,[31] and refined by full-matrix least-
squares on F2. All non-hydrogen atoms were included in the model
at their calculated positions.
CCDC-250084 (1), -255498 (2), -255497 (3), -269987 (7), and
-269988 (10) contain the supplementary crystallographic data for
this paper. These data can be obtained free of charge from The
Cambridge Crystallographic Data Center via www.ccdc.cam.ac.uk/
data_request/cif.
H 4.77, N 3.01; found C 58.25, H 4.53, N 3.11. IR (KBr): ν =
˜
3411 cm–1 (m, OH), 3035 (s, Ph–H), 2952, 2859 (s, C–H), 1630 (s,
C=N), 1596, 1347 (s, CO2), 1579 (m, C=N–N=C), 1202 (s, C–O),
1
679 (m, Sn–O), 555 (m, Sn–C), 477 (w, Sn–N). H NMR (CDCl3,
400 MHz): δ = 2.65 (d, J = 5.60 Hz, 3 H, CH3), 2.81 (t, JSn,H
=
68.88 Hz, 6 H, ArCH2Sn), 3.16 (s, 4 H, ArCH2Sn), 6.93–7.28 (m,
29 H, Ar-H and Ph-H), 11.43 (s, 1 H, Ar-OH) ppm. 119Sn NMR
(CDCl3): δ = 111.7, –449.5 ppm.
[(pCNBz)2Sn{2-HOC6H4CON2C(CH3)CO2}{(pCNBz)3SnOH}]2
(9): Complex 9 was prepared in the same way as 7 by adding bis(tri-
p-cyanobenzyltin) oxide (1.0 mmol) to pyruvic acid salicylhydra-
zone (1.0 mmol). The solid was then obtained from dichlorometh-
ane/hexane. Yield: 93% (99.7 mg). M.p. 218 °C. C50H38N7O5Sn2
(1054.30): calcd. C 56.91, H 3.72, N 9.29; found C 57.15, H 3.55,
Supporting Information (see footnote on the first page of this arti-
cle): Figures S1, S2, S3, and S4 show the unit cell of complexes 2,
3, 7, and 10, respectively Crystal data and details of the structure
determinations are listed in Tables S1 and S2.
N 9.21. IR (KBr): ν = 3423 cm–1 (s, OH), 3017 (s, Ph–H), 2988,
˜
2889 (m, C–H), 1621 (m, C=N), 1606, 1367 (s, CO2), 1542 (s, C=N–
N=C), 1211 (s, C–O), 674 (m, Sn–O), 547 (w, Sn–C), 485 (w, Sn–
1
N). H NMR (CDCl3, 400 MHz): δ = 2.44 (d, J = 5.40 Hz, 3 H,
CH3), 2.79 (t, JSn,H = 65.48 Hz, 6 H, ArCH2Sn), 3.22 (s, 4 H, Acknowledgments
ArCH2Sn), 6.81–7.42 (m, 24 H, Ar-H and Ph-H), 10.91 (s, 1 H,
Ar-OH) ppm. 119Sn NMR (CDCl3): δ = 109.5, –452.3 ppm.
We acknowledge the financial support of the Natural Science
Foundation of China (no. 20271025), the Shandong Province Sci-
ence Foundation (no. L2003B01), and the State Key Laboratory of
Crystal Materials, Shandong University, P. R. China.
[(oClBz)2Sn{2-HOC6H4CON2C(CH3)CO2}(CH3OH)]2 (10): Pyru-
vic acid salicylhydrazone (2.0 mmol) and tri-o-chlorobenzyltin
chloride (2.0 mmol) were added to a solution of absolute toluene
(30 mL) and heated under reflux, with stirring, for 1 h. After the
addition of triethylamine (2.0 mmol) to the reactor, the reaction
mixture was refluxed for 1 h more. The clear solution thus obtained
[1] L. Sacconi, Coord. Chem. Rev. 1966, 1, 126–142.
[2] S. Yamada, Coord. Chem. Rev. 1966, 1, 415–441.
4580
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2005, 4572–4581